These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 6778990

  • 1. Dose-dependent pharmacokinetics of tocainide in the rat.
    Venkataramanan R, Axelson JE.
    J Pharmacol Exp Ther; 1980 Oct; 215(1):231-4. PubMed ID: 6778990
    [Abstract] [Full Text] [Related]

  • 2. The effect of phenobarbital and SKF 525A on tocainide pharmacokinetics in the rat.
    Venkataramanan R, Axelson JE.
    J Pharmacol Exp Ther; 1980 Oct; 215(1):235-9. PubMed ID: 6778991
    [Abstract] [Full Text] [Related]

  • 3. Disposition of (R,S)-tocainide. Some stereoselective aspects.
    Gal J, French TA, Zysset T, Haroldsen PE.
    Drug Metab Dispos; 1982 Oct; 10(4):399-404. PubMed ID: 6126341
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Metabolism of tocainide in the rat.
    Venkataramanan R, Abbott FS, Axelson JE.
    J Pharm Sci; 1982 May; 71(5):491-4. PubMed ID: 6808112
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Tocainide conjugation in humans: novel biotransformation pathway for a primary amine.
    Elvin AT, Keenaghan JB, Byrnes EW, Tenthorey PA, McMaster PD, Takman BH, Lalka D, Manion CV, Baer DT, Wolshin EM, Meyer MB, Ronfeld RA.
    J Pharm Sci; 1980 Jan; 69(1):47-9. PubMed ID: 7354440
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of tocainide in acute myocardial ischaemia.
    Sutton PP.
    Br J Clin Pharmacol; 1980 Nov; 10(5):530-1. PubMed ID: 6776976
    [No Abstract] [Full Text] [Related]

  • 9. Route-dependent nonlinear pharmacokinetics of a novel HIV protease inhibitor: involvement of enzyme inactivation.
    Lin JH, Chen IW, Chiba M, Nishime JA, Deluna FA.
    Drug Metab Dispos; 2000 Apr; 28(4):460-6. PubMed ID: 10725315
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
    Thompson KL, Vincent SH, Miller RR, Colletti AE, Alvaro RF, Wallace MA, Feeney WP, Chiu SH.
    Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Absorption, disposition kinetics, and metabolic pathways of cyclohexene oxide in the male Fischer 344 rat and female B6C3F1 mouse.
    Sauer JM, Bao J, Smith RL, McClure TD, Mayersohn M, Pillai U, Cunningham ML, Sipes IG.
    Drug Metab Dispos; 1997 Mar; 25(3):371-8. PubMed ID: 9172957
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.